Graves' disease in children and adolescents. Late results of surgical treatment

European Journal of Endocrinology

Volumn 134, Issue 6, 1996, Pages 710-715

  Rudberg, Claes ^a   Johansson, Henry ^a   Åkerström, Göran ^a   Tuvemo, Torsten ^a   Karlsson, F Anders ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; LEVOTHYROXINE; PROPRANOLOL; PROPYLTHIOURACIL; THIAMAZOLE; VITAMIN D;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; GRAVES DISEASE; HUMAN; HYPOCALCEMIA; HYPOTHYROIDISM; MALE; PRIORITY JOURNAL;

EID: 0029989776     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1340710     Document Type: Article

References (40)

1. Buckingham BA, Costin G, Roe TF, Weitzman JJ, Kogut MD. Hyperthyroidism in children. A reevaluation of treatment. Am J Dis Child 1981;135:112-7
2. Levy WJ, Schumacher OP, Gupta M. Treatment of childhood Graves' disease. A review with emphasis on radioiodine treatment. Cleve Clin J Med 1988;55:373-82
3. Zimmerman D, Gan-Gaisano M. Hyperthyroidism in children and adolescents, Pediatr Clin North Am 1990;37:1273-95
4. Berglund J, Christensen SB, Hallengren B. Total and age-specific incidence of Graves' thyrotoxicosis, toxic nodular goitre and solitary toxic adenoma in Malmö 1970-74. J Intern Med 1990; 227:137-41
5. Wide L. Radioimmunoassays employing immunosorbents. Acta Endocrinol (Copenh) Suppl 1969;142:207-18
6. Barnes HV, Blizzard RM. Antithyroid drug therapy for toxic diffuse goiter (Graves' disease): thirty years experience in children and adolescents. J Pediatr 1977;91:313-20
7. Winsa B, Dahlberg PA, Jansson R, Ågren H, Karlsson FA. Prognostic factors in Graves' disease. Acta Endocrinol (Copenh) 1990;122:722-8
8. Laurberg P, Bucholtz Hansen PE, Iversen E, Jensen SE, Weeke J. Goitre size and outcome of medical treatment of Graves' disease. Acta Endocrinol (Copenh) 1986;111:39-42
9. Lippe BM, Landaw EM, Kaplan SA. Hyperthyroidism in children treated with long term medical therapy: twenty-five per cent remission every two years. J Clin Endocrinol Metab 1987;64: 1241-5
10. Vaidya VA, Bongiovanni AM, Parks JS, Tenore A, Kirkland RT. Twenty-two years' experience in the medical management of juvenile thyrotoxicosis. Pediatrics 1974;54:565-70
11. Mäenpää J, Kuusi A. Childhood hyperthyroidism. Results of treatment. Acta Pædiatr Scand 1980;69:137-42
12. Rallison ML, Dobyns BM, Keating FR, Rall JE, Tyler FH. Occurrence and natural history of chronic lymphocytic thyroiditis in childhood. J Pediatr 1975;86:675-82
13. Riddervold F. Natural course of intermittent chronic autoimmune thyroiditis. Acta Endocrinol (Copenh) 1983;102:46-8
14. Solem JH, Svaar H. A case of untreated chrome goitrous autoimmune thyroiditis with spontaneous fluctuation between different metabolic levels. Acta Endocrinol (Copenh) 1984;105: 24-7
15. Inomata H, Tsuyusaki T, Sasaki N, Tamaru K, Niimi H, Nakajima H. A patient with Graves' disease who developed hypothyroidism associated with thyroid stimulation blocking immunoglobulin during anti-thyroid drug therapy. Endocrinol Jpn 1988;35:379-84
16. Cutler AT, Benezra-Obeiter R, Brink SJ. Thyroid function in young children with Down syndrome. Am J Dis Child 1986;140:479-83
17. Crinò A, Ciampalini P, DiGilio MC, Obregon MG, Giannotti A, Borrelli P. Abnormal thyrotropin secretion in Down's syndrome. In: Castells S, Wisniewski KE, editors. Growth hormone treatment in Down's syndrome. New York: Wiley, 1993:102-9
18. Zori RT, Schatz DA, Ostrer H, Williams CA, Spillar R, Riley WJ. Relationship of autoimmunity to thyroid dysfunction in children and adults with Down syndrome. Am J Med Genet Suppl 1990;7:238-41
19. Refetoff S, Harrison J, Karanfilski BT, Kaplan EL, DeGroot LJ, Bekerman C. Continuing occurance of thyroid carcinoma after irradiation to the neck in infancy and childhood. N Engl J Med 1975;292:171-5
20. Braverman LE. Consequences of thyroid radiation in children. N Engl J Med 1975;292:204-5
21. 131I) for hyperthyroidism. N Engl J Med 1975;292:168-70
22. Crile G. The treatment of hyperthyroidism. World J Surg 1978;2: 279-80
23. Baverstock KF. Thyroid cancer in children in Belarus after Chernobyl. WHO Health Stat Q 1993;46:204-8
24. Tezelman S, Grossman RF, Siperstein AE, Clark OH. Radioiodine associated thyroid cancers. World J Surg 1994;18:522-8
25. Karlsson FA, Dahlberg PA, Jansson R, Westermark K, Enoksson P. Importance of TSH receptor activation in the development of severe endocrine ophthalmopathy. Acta Endocrinol (Copenh) 1989;121 Suppl 2:132-41
26. DeGrott LJ, Gorman CA, Pinchera A, et al. Therapeutic controversies: radiation and Graves' ophthalmopathy. J Clin Endocrinol Metab 1995;80:339-40
27. Thompson NW, Dunn EL, Freitas JE, Sisson JC, Coran AG, Nishiyama RH. Surgical treatment of thyrotoxicosis in children and adolescents. J Pediatr Surg 1977;12:1009-18
28. Perzik SL. Total thyroidectomy in Graves' disease in children. J Pediatr Surg 1976;11:191-3
29. Wesley JR, Buckingham BA, Gahr JA, Isaacs H, Kogut MD, Weitzman JJ. Surgical treatment of hyperthyroidism in children. SGO 1977;145:343-6
30. Barnes HV. Treatment of hyperthyroidism in children and adolescents. Pharmacol Ther C 1976;1:129-47
31. Noguchi S, Murakami N, Noguchi A. Surgical treatment for Graves' disease: a long term follow-up of 325 patients. Br J Surg 1981;68:105-8
32. Lee TC, Coffey RJ, Currier BM, et al. Propranolol and thyroidectomy in the treatment of thyrotoxicosis. Ann Surg 1982; 195:766-73
33. Sugrue DD, Drury MI, McEvoy M, et al. Long-term follow-up of hyperthyroid patients treated by subtotal thyroidectomy. Br J Surg 1983;70:408-11
34. Harade T, Shimaoka K, Arita S, et al. Follow-up evaluation of thyroid function after thyroidectomy of thyrotoxicosis. World J Surg 1984;8:436-44
35. Maier WP, Derrik BM, Marks AD, et al. Long-term follow-up of patients with Graves' disease treated by subtotal thyroidectomy. Am J Surg 1984;147:266-8
36. Cusick EL, Krukowski ZH, Matheson NA. Outcome of surgery for Graves' disease re-examined. Br J Surg 1987;74:780-3
37. Jörtsö E, Lennquist S, Lundström B, et al. The influence of remnant size, antithyroid antibodies, thyroid morphology. and lymphocyte infiltration on thyroid function after subtotal resection for hyperthyroidism. World J Surg 1987;11:365-71
38. Ozoux JP, de Calan L, Portier G, et al. Surgical treatment of Graves' disease. Am J Surg 1988;156:177-81
39. Kasuga Y. Sugenoya A, Kobayashi S, et al. Clinical evaluation of the response to surgical treatment of Graves' disease. Surg Gynecol Obstet 1990;170:327-30
40. Winsa B, Rastad J, Larsson E, Mandahl A, Westermark K, Johansson H, et al. Total thyroidectomy in therapy-resistant Graves' disease. Surgery 1994;116(6):1068-75